Form4insider filings, from the source

SEC Form 4 · accession 0001144204-16-124443

Aclaris Therapeutics, Inc. · ACRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Sep 15, 2016
Accepted (ET)
Sep 19, 2016 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 15, 2016S20,000$24.035D2,607,719ISee Footnote
Common StockF1Sep 15, 2016S273,000$24.00D2,334,719ISee Footnote
Common StockF1Sep 15, 2016S58,950$24.20D2,275,769ISee Footnote
Common StockF1Sep 16, 2016S150,000$24.50D2,125,769ISee Footnote
Common StockF2,F1Sep 16, 2016S23,600$24.5429D2,102,169ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses